Consensus or confusion: A review of existing national guidelines on Helicobacter pylori-related disease

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 5, 1997, Pages 527-531

  Lee, John ^a   O'Morain, Colm ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Consensus; Guidelines; Helicobacter pylori; Treatment

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; NITROIMIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; TINIDAZOLE;

DUODENUM ULCER; DYSPEPSIA; ENDOSCOPY; EUROPE; GASTROESOPHAGEAL REFLUX; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; LYMPHOID TISSUE; LYMPHOMA; PEPTIC ULCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; STOMACH DISEASE; STOMACH ULCER; UNITED STATES;

EID: 0030946883     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199705000-00021     Document Type: Short Survey

References (37)

1. Warren JR, Marshall BJ: Unidentified curved bacilli on the gastric epithelium in active chronic gastritis. Lancet 1983, i:1273-1275.
2. Coghlan JG, Gilligan DH, Humphries H, et al.: Campylobacter pylori and recurrence of duodenal ulcers - a 12-month follow-up study. Lancet 1987, ii:1109-1111.
3. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease: Helicobacter pylori in peptic ulcer disease. JAMA 1994, 272:65-69.
4. Buckley M and the Irish Helicobacter pylori Study Group: Guidelines for the management of Helicobacter pylori-related upper gastrointestinal diseases, Ir J Med Sci 1996, 165(suppl. 5):1-11.
5. Gaspary WF, Arnold R, Bayerdorffer E, et al.: Diagnostic und Therapie der Helicobacter-pylori-Infektion. Z Gastroenterol 1996, 34:392-401.
6. Bolin I, Carling S, Danielsson A, et al: Ny klinisk strategi vid peptisk ulcussjukdom. Rad om elimination av Helicobacter pylori. Lakartidningen 1994, 19:1925-1932.
7. The Polish Working Group on Helicobacter pylori: Leczenie zakazenia Helicobacter pylori. Diaczego? Kiedy? W jaki sposob? (The treatment of the Helicobacter pylori infection. Why? When? How?). Gastroenterologia Polska 1996, 3(1):5-14.
8. Farkilla M, Julkunen R, Niemela S, et al.: Helicobacter pylori-infektion diagnostiikasta, hoidosta ja seurannasta. Suomen Laakarilehti 1996, 51:9-13.
9. Groupe d'Etude Français des Helicobacters (GEFH): Helicobacter pylori. La Lettre de l'Infectiologue 1996, 11(suppl. 5):3-47.
10. Professional Advisory Panel (CRAG) and Scottish Intercollegiate Guidelines Network (SIGN): Helicobacter pylori eradication therapy in dyspeptic disease: a clinical guideline. SIGN; 1996.
11. Burette A, Delentre M, Debongnie JC, et al.: Premiere reunion de consensus belge sur l'attitude therapeutique a adopter face à I'Helicobacter pylori. Gastro-enterologie 1996:31-33.
12. Patel P, Khulisi S, Mendall MA, et al.: Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet 1995, 346:1315-1318.
13. Hoskings W, Young MY, Chung SC, et al.: Differing prevalence of Helicobacter pylori in bleeding and non-bleeding ulcers. Gastroenterology 1992, 102:A85.
14. Debongnie JC, Legross G: Gastric perforation: an acute disease unrelated to H. pylori? Rev Esp Enferm Dig 1990, 78(suppl. 1):71-72.
15. Reinbach DH, Cruickshank G, McColl KEL: Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut 1993, 34:1344-1347.
16. Rokkas T, Karameris A, Mavrogeorgis A, et al.: Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995, 41:1-4.
17. Graham DY, Hepps KS, Ramirez FC, et al.: Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993, 28:939-942.
18. Jaspersen D, Koerner T, Schorr W, et al.: Helicobacter pylori eradication reduces the rate of rebleeding in ulcer haemorrhage. Gastrointest Endosc 1995, 41:5-7.
19. Goh KL, Parasakthi N, Peh SC, et al.: Helicobacter pylori eradication with short-term therapy leads to duodenal ulcer healing without the need for continued acid suppressing therapy. Eur J Gastroenterol Hepatol 1996, 8:421-423.
20. Buckley M, O'Morain C: Helicobacter pylori eradication - a surrogate marker for duodenal ulcer healing. Eur J Gastroenterol Hepatol 1996, 8:415-416.
21. O'Connor HJ, Dixon MF, Wyatt JJ, et al.: Campylobacter pylori and peptic ulcer disease. Lancet 1987, ii:633-634.
22. Hui WM, Lam SK, Chan PY, et al.: Campylobacter pyloridis in gastric ulcer. J Gastroenterol Hepatol 1987, 2:309-316.
23. Niemela S, Karttunen T, Lehtola J: Campylobacter-like organisms in patients with gastric ulcer. Scand J Gastroenterol 1987, 22:487-490.
24. Taha AS, Russell RI: Helicobacter pylori and non-steroidal antiinflammatory drugs: uncomfortable partners in peptic ulcer disease. Gut 1993, 34:580-583.
25. McCarthy DM: Helicobacter pylori infection and gastroduodenal injury by non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1991, 26(suppl. 187):91-97.
26. Heresbach D, Raol JL, Bretagne JF, et al.: Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy. Gut 1992, 33:1608-1611.
27. O'Connor HJ, Cunnane K: Helicobacter pylori and gastrooesophageal reflux disease - a prospective study. Irish J Med Sci 1994, 163:369-373.
28. Lee J, Breslin N, O'Morain C: Is there an association between Helicobacter pylori infection and reflux oesophagitis? Irish J Med Sci 1996, 165(suppl. 4):A10.
29. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al.: Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996, 334:1018-1022.
30. Talley NJ: A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994, 106:1174-1183.
31. McCarthy C, Patchett S, Keane C, et al.: Long term prospective study in the role of Helicobacter pylori in non-ulcer dyspepsia. Dig Dis Sci 1995, 40:114-119.
32. Richter JE: Dyspepsia: organic causes and differential characteristics from functional dyspepsia. Scand J Gastroenterol 1991, 26:(suppl. 182):11-16.
33. Jones RH, Lydeard SE, Hobbs FD, et al.: Dyspepsia in England and Scotland. Gut 1990, 31:401-405.
34. Jones R, Lydeard S: Prevalence of symptoms of dyspepsia in the community. BMJ 1989, 298:30-32.
35. Neale KR, Logan RPH: The epidemiology and transmission of Helicobacter pylori infection in children. Aliment Pharmacol Ther 1995, 9(suppl. 2):77-84.
36. Blaser MJ, Chyou PH, Nomura A: Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk. Cancer Res 1995, 55:562-565.
37. Malfertheiner P, Megraud F, O'Morain C, et al. for the European Helicobacter pylori Study Group (EHPSG). Current European concepts in the management of Helicobacter pylori infection - The Maastricht Consensus Report. Eur J Gastroenterol Hepatol 1997, 9:1-2.